Vaxart, Inc. (VXRT)
0.5016
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Vaxart Total Assets (Quarterly) : 165.18M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 165.18M |
| March 31, 2026 | 180.06M |
| December 31, 2025 | 190.46M |
| September 30, 2025 | 208.99M |
| June 30, 2025 | 164.08M |
| March 31, 2025 | 158.56M |
| December 31, 2024 | 166.39M |
| September 30, 2024 | 166.67M |
| June 30, 2024 | 113.75M |
| March 31, 2024 | 88.67M |
| December 31, 2023 | 91.83M |
| September 30, 2023 | 105.64M |
| June 30, 2023 | 122.65M |
| March 31, 2023 | 129.85M |
| December 31, 2022 | 153.85M |
| September 30, 2022 | 175.31M |
| June 30, 2022 | 181.45M |
| March 31, 2022 | 200.38M |
| December 31, 2021 | 221.17M |
| September 30, 2021 | 241.14M |
| June 30, 2021 | 228.84M |
| March 31, 2021 | 205.87M |
| December 31, 2020 | 152.58M |
| September 30, 2020 | 154.71M |
| June 30, 2020 | 64.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 52.56M |
| December 31, 2019 | 37.03M |
| September 30, 2019 | 42.70M |
| June 30, 2019 | 37.25M |
| March 31, 2019 | 36.31M |
| December 31, 2018 | 35.23M |
| September 30, 2018 | 40.64M |
| June 30, 2018 | 47.76M |
| March 31, 2018 | 56.54M |
| June 30, 2017 | 40.10M |
| March 31, 2017 | 46.70M |
| December 31, 2016 | 56.50M |
| September 30, 2016 | 63.10M |
| June 30, 2016 | 72.70M |
| March 31, 2016 | 61.90M |
| December 31, 2015 | 64.20M |
| September 30, 2015 | 71.00M |
| June 30, 2015 | 79.40M |
| March 31, 2015 | 88.80M |
| December 31, 2014 | 93.40M |
| September 30, 2014 | 97.30M |
| June 30, 2014 | 114.00M |
| March 31, 2014 | 120.50M |
| December 31, 2013 | 82.70M |
| September 30, 2013 | 79.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.81M |
| Shareholders Equity (Quarterly) | 82.37M |
| Debt to Equity Ratio | 0.1522 |
| Current Ratio | 1.596 |
| Net Debt Paydown Yield | 1.09% |